Enovis Announces Second Quarter 2022 Results
August 04, 2022 06:00 ET
|
Enovis Corporation
Sales of $395 million include 11% reported growth, 3% organic growth and 5% sales-per-day growthReported operating income of $6 million, while adjusted EBITDA increased 11% to $56...
Enovis to Host Second Quarter 2022 Conference Call on August 4th
July 12, 2022 16:01 ET
|
Enovis Corporation
Wilmington, DE, July 12, 2022 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call...
Enovis Completes Acquisition of Insight Medical Systems
July 06, 2022 08:00 ET
|
Enovis Corporation
WILMINGTON, DE, July 06, 2022 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, announced that it has acquired Insight Medical Systems, a...
Enovis Announces Chief Financial Officer Transition Plan
June 30, 2022 08:00 ET
|
Enovis Corporation
Wilmington, DE, June 30, 2022 (GLOBE NEWSWIRE) -- Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, today announced that Ben Berry, CFO of the Company’s...
Enovis to Participate in the Goldman Sachs Global Healthcare Conference
June 06, 2022 16:05 ET
|
Enovis Corporation
Wilmington, DE, June 06, 2022 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company formerly known as Colfax Corporation, will participate in...
Enovis Announces First Quarter 2022 Adjusted Stand Alone Results
May 10, 2022 07:11 ET
|
Enovis Corporation
Wilmington, DE, May 10, 2022 (GLOBE NEWSWIRE) -- Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology growth company formerly known as Colfax Corporation, today announced its...
Enovis Schedules First Quarter 2022 Earnings Release and Conference Call
April 14, 2022 13:23 ET
|
Enovis Corporation
Wilmington, DE, April 14, 2022 (GLOBE NEWSWIRE) -- Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology growth company formerly known as Colfax Corporation, today announced...
Enovis (formerly Colfax) Completes Spin-off of ESAB Corporation
April 05, 2022 06:00 ET
|
Enovis Corporation
Wilmington, DE, April 05, 2022 (GLOBE NEWSWIRE) -- Enovis Corporation (“Enovis” or the “Company”) (NYSE: ENOV), an innovation-driven medical technology growth company formerly known as Colfax...
Colfax Announces Board of Directors for Post-Spinoff ESAB
March 28, 2022 06:30 ET
|
Colfax Corporation
Wilmington, DE, March 28, 2022 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company which will renamed Enovis Corporation (“Enovis”) following the expected...
Colfax Announces Expected Completion Date of April 4, 2022 for Spin-Off of ESAB Corporation
March 14, 2022 16:33 ET
|
Colfax Corporation
“When-issued” trading of ESAB and Colfax ex-distribution common stock expected to begin on March 21, 2022Record date for distribution of ESAB common stock will be March 22, 2022Distribution Date...